ripekg:evaluation/RIPEA01514B7E95B5311F |
prov:used |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
rdf:type |
rdfs:Resource |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
rdf:type |
owl:Thing |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
rdf:type |
ripe:RegistryEvidenceRegistry evidence |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
rdf:type |
tido:Evidence |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
prov:wasAttributedTo |
ripekg:source/who-ictrpWHO ICTRP |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
prov:wasAttributedTo |
ripekg:source/who-ictrpWHO International Clinical Trials Registry Platform |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA01514B7E95B5311F |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA01514B7E95B5311F |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripe:concerns |
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripe:isProspective |
true |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripe:registrationAssessmentRationale |
Comparison performed at month level. Registration: 2015-02, LLM Recruitment Start: 2015-02. Deemed prospective at month level. |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripe:registrationDate |
2015-02-09 |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripe:registrationId |
IRCT201502055623N34 |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripe:registrationLink |
https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT201502055623N34 |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
ripe:registryName |
IRCT |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA01514B7E95B5311F-human-2-2 |
ripekg:registry-evidence/RIPEA01514B7E95B5311F |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA01514B7E95B5311F-inspectai-2-2 |